DJ Gilead Sciences Inc. Stock Outperforms Competitors On Strong Trading Day
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Gilead Sciences Inc. (GILD) rallied 1.87% to $146.41 Monday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index falling 0.48% to 7,619.98 and Dow Jones Industrial Average falling 0.29% to 52,421.20.
The stock's rise snapped a five-day losing streak.
Gilead Sciences Inc. closed 6.92% below its 52-week high of $157.29, which the company achieved on February 11th.
The stock outperformed some of its competitors Monday, as Johnson & Johnson $(JNJ)$ rose 0.28% to $266.32, Pfizer Inc. $(PFE)$ remained unchanged, and Abbott Laboratories $(ABT)$ rose 1.12% to $103.09.
Trading volume (4.8 M) remained 1.5 million below its 50-day average volume of 6.3 M.
Data source: Dow Jones Market Data, FactSet. Data compiled September 14, 2026.